Delivery Order SPE2DB20D2014-SPE2DB24FC68T
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,637.46, is for the delivery of Clindamycin Phosphate 1% Foam, 50GM. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of December 26, 2024. The contract is not designated as a set-aside and represents an open competition award....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $1,437.66, is for the supply of 4563957329 - CLINDAMYCIN PHOSPHATE 1% FOAM 100GM. The contract has a period of performance ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560408677 - Clindamycin Phosphate 1% Foam 50GM, with a ceiling value of $2,433.39 and a completion date of March 29, 2023. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,428.66 firm fixed-price contract is for the delivery of Clindamycin Phosphate 1% Foam, a topical antibiotic medication, with a period of performance through October 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4558478384 - Clindamycin Phosphate 1% Foam, 100 gm, with a ceiling value of $1,339.74 and a completion date of September 16, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563335833 - Clindamycin Phosphate 1% Foam, 50 grams. The contract has a ceiling value of $1,568.55 and an ultimate completion date of January 17, 2024. This is a firm-fixed-price contract without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,364.86 firm fixed price contract is for the supply of Clindamycin Phosphate 1% Foam, a prescription medication, with a completion date of June 10, 2024. This order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a $1,299.44 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any special designation....
This federal contract award, valued at $1,338.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566367930 - Clindamycin Phosphate 1% Foam, 50GM. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 1, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,459.81 firm-fixed-price delivery order is for the supply of 4566143778 - Clindamycin Phosphate 1% Foam, 100GM. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...